英科再生(688087) - 2025 Q1 - 季度财报

Financial Performance - The company achieved operating revenue of CNY 792.65 million in Q1 2025, representing a year-on-year increase of 25.19%[5] - Net profit attributable to shareholders was CNY 72.32 million, showing a slight increase of 0.02% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses decreased by 32.40% to CNY 47.43 million[5] - Total operating revenue for Q1 2025 reached RMB 792,651,181.88, an increase of 25.2% compared to RMB 633,138,354.98 in Q1 2024[21] - Total revenue from operating activities increased to CNY 750,797,388.50 in Q1 2025, compared to CNY 616,029,333.22 in Q1 2024, reflecting a growth of approximately 21.8%[25] - The total comprehensive income for Q1 2025 was CNY 73,232,968.47, compared to CNY 68,678,030.73 in Q1 2024, showing an increase of approximately 6.5%[23] - The basic and diluted earnings per share remained stable at CNY 0.39 for both Q1 2025 and Q1 2024[23] Cash Flow and Assets - The net cash flow from operating activities increased by 44.46% to CNY 95.61 million, driven by higher cash receipts from sales[10] - The company reported a net cash flow from operating activities of CNY 95,612,915.58 for Q1 2025, compared to CNY 66,187,257.87 in Q1 2024, representing a growth of approximately 44.5%[26] - Cash and cash equivalents decreased to RMB 862,071,318.10 from RMB 1,170,230,693.72, a decline of 26.3%[17] - Cash and cash equivalents at the end of Q1 2025 were CNY 861,571,052.10, down from CNY 1,102,386,423.02 at the end of Q1 2024, indicating a decrease of about 21.9%[27] - The company reported a net cash outflow from investing activities of CNY 283,502,039.54 in Q1 2025, compared to a net outflow of CNY 298,492,820.88 in Q1 2024, showing a slight improvement[26] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 6.27 billion, up 13.86% from the end of the previous year[6] - Current assets as of March 31, 2025, totaled RMB 4,141,847,820.41, a 20.9% increase from RMB 3,426,029,693.05 at the end of 2024[17] - Total assets increased to RMB 6,269,202,936.76 as of March 31, 2025, compared to RMB 5,506,042,401.17 at the end of 2024, marking a growth of 13.9%[18] - Total liabilities rose to RMB 3,660,924,768.33, up from RMB 2,971,744,405.87, indicating a 23.2% increase[19] - Shareholders' equity as of March 31, 2025, was RMB 2,608,278,168.43, compared to RMB 2,534,297,995.30 at the end of 2024, reflecting a growth of 2.9%[19] Research and Development - Research and development expenses totaled CNY 31.41 million, accounting for 3.96% of operating revenue, a decrease of 0.17 percentage points[6] - Research and development expenses rose to CNY 31,405,965.12 in Q1 2025, up from CNY 26,168,596.76 in Q1 2024, marking an increase of about 20%[22] Shareholder Information - The company reported a total of 6,716 common shareholders at the end of the reporting period[12] - The top shareholder, Zibo Yazhi Investment Co., Ltd., holds 32.67% of the shares[12] Financial Ratios - The weighted average return on equity decreased to 2.81%, down 0.37 percentage points from the previous year[6] - The company incurred financial expenses of CNY 17,529,486.33 in Q1 2025, a significant change from a financial income of CNY 26,277,801.67 in Q1 2024[22] Market Strategy - The company continues to focus on new product development and expanding marketing channels to enhance market competitiveness[6]